High-content assays for ligand regulation of G-protein-coupled receptors

Drug Discovery Today

Volumn 8, Issue 13, 2003, Pages 579-585

  Milligan, Graeme ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Beta arrestins; Biochemistry; Drug Discovery; G protein coupled receptors; Green fluorescent protein; Multiplexed assays; Pharmaceutical Science; Pharmacology; Protein translocation

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; G PROTEIN COUPLED RECEPTOR; LIGAND; RETINA S ANTIGEN; UNCLASSIFIED DRUG;

HUMAN; LIGAND BINDING; NONHUMAN; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; REVIEW;

ANIMALS; GENOME, HUMAN; GTP-BINDING PROTEIN REGULATORS; HUMANS; LIGANDS; RECEPTORS, CELL SURFACE; TECHNOLOGY, PHARMACEUTICAL;

EID: 0038380750     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02738-7     Document Type: Review

References (60)

1. Venter J.C., et al. The sequence of the human genome. Science. 291:2001;1304-1351.
2. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
3. Vassilatis D.K., et al. The G protein-coupled receptor repertoires of human and mouse. Proc. Natl. Acad. Sci. U. S. A. 100:2003;4903-4908.
4. Wilson S., Bergsma D. Orphan G-protein coupled receptors: novel drug targets for the pharmaceutical industry. Drug Des. Discov. 17:2000;105-114.
5. Wise A., et al. Target validation of G-protein coupled receptors. Drug Discov. Today. 7:2002;235-246.
6. Milligan G. Strategies to identify ligands for orphan G-protein-coupled receptors. Biochem. Soc. Trans. 30:2002;789-793.
7. Szekeres P.G. Functional assays for identifying ligands at orphan G protein-coupled receptors. Recept. Channels. 8:2002;297-308.
8. Moore K., Rees S. Cell-based versus isolated target screening: how lucky do you feel? J. Biomol. Screen. 6:2001;69-74.
9. Dupriez V.J., et al. Aequorin-based functional assays for G-protein-coupled receptors, ion channels and tyrosine kinase receptors. Recept. Channels. 8:2002;319-330.
10. Hill S.J., et al. Reporter-gene systems for the study of G-protein-coupled receptors. Curr. Opin. Pharmacol. 1:2001;526-532.
11. Conway B.R., Demarest K.T. The use of biosensors to study GPCR function: Applications for high content screening. Recept. Channels. 8:2002;331-341.
12. Zhang J., et al. Creating new fluorescent probes for cell biology. Nat. Rev. Mol. Cell Biol. 3:2002;906-918.
13. Meyer T., Oancea E. Studies of signal transduction events using chimeras to green fluorescent protein. Methods Enzymol. 327:2000;500-513.
14. Sorkin A., Von Zastrow M. Signal transduction and endocytosis: close encounters of many kinds. Nat. Rev. Mol. Cell Biol. 3:2002;600-614.
15. Tsao P.I., von Zastrow M. Diversity and specificity in the regulated endocytic membrane trafficking of G-protein-coupled receptors. Pharmacol. Ther. 89:2001;139-147.
16. Barak L.S., et al. Internal trafficking and surface mobility of a functionally intact β2-adrenergic receptor-green fluorescent protein conjugate. Mol. Pharmacol. 51:1997;177-184.
17. Kallal L., Benovic J.L. Using green fluorescent proteins to study G-protein-coupled receptor localization and trafficking. Trends Pharmacol. Sci. 21:2000;175-180.
18. Milligan G. Exploring the dynamics of regulation of G protein-coupled receptors using green fluorescent protein. Br. J. Pharmacol. 128:1999;501-510.
19. Roettger B.F., et al. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol. Pharmacol. 51:1997;357-362.
20. Petaja-Repo U.E., et al. Newly synthesized human δ opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J. Biol. Chem. 276:2001;4416-4423.
21. Conway B.R., et al. Quantitative analysis of agonist-dependent parathyroid hormone receptor trafficking in whole cells using a functional green fluorescent protein conjugate. J. Cell. Physiol. 189:2001;341-355.
22. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53:2001;1-24.
23. Barak L.S., et al. A β-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J. Biol. Chem. 272:1997;27497-27500.
24. Oakley R.H., et al. Differential affinities of visual arrestin, β arrestin1, and β arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem. 275:2000;17201-17210.
25. Oakley R.H., et al. The cellular distribution of fluorescently labelled arrestins provides a robust, sensitive and universal assay for screening G protein-coupled receptors. Assays Drug Develop. Tech. 1:2002;21-30.
26. Bertrand L., et al. The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRS). J. Recept. Signal Transduct. Res. 22:2002;533-541.
27. Berglund, M.M. et al. The use of bioluminescence resonance energy transfer (BRET2) to study neuropeptide Y receptor agonist induced {β}-arrestin 2 interaction. J. Pharmacol. Exp. Ther. (in press).
28. Balla T., et al. How accurately can we image inositol lipids in living cells? Trends Pharmacol. Sci. 21:2000;238-241.
29. 2+ and inositol 1,4,5-trisphosphate oscillation frequency. Receptor density versus agonist concentration. J. Biol. Chem. 277:2002;35947-35960.
30. Chalmers D.T., Behan D.P. The use of constitutively active GPCRs in drug discovery and functional genomics. Nat. Rev. Drug Discov. 1:2002;599-608.
31. Gether U., et al. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J. Biol. Chem. 272:1997;2587-2590.
32. Lee T.W., et al. Up-regulation of the levels of expression and function of a constitutively active mutant of the hamster α1B-adrenoceptor by ligands that act as inverse agonists. Biochem. J. 325:1997;733-739.
33. MacEwan D.J., Milligan G. Inverse agonist-induced up-regulation of the human β2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells. Mol. Pharmacol. 50:1996;1479-1486.
34. Li J., et al. Inverse agonist upregulates the constitutively active D3.49(164)Q mutant of the rat μ-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulation. Mol. Pharmacol. 60:2001;1064-1075.
35. Milligan G., et al. Ligand rescue of constitutively active mutant receptors. Neurosignals. 11:2002;29-33.
36. Milligan G., Bond R.A. Inverse agonism and the regulation of receptor number. Trends Pharmacol. Sci. 18:1997;468-474.
37. McLean A.J., et al. Visualizing differences in ligand regulation of wild-type and constitutively active mutant β(2)-green fluorescent protein fusion proteins. Mol. Pharmacol. 56:1999;1182-1191.
38. 1b-adrenoceptor. Mol. Pharmacol. 58:2000;438-448.
39. Ramsay D., et al. Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G protein-coupled receptor. Br. J. Pharmacol. 133:2001;315-323.
40. 1-adrenoceptor. Mol. Pharmacol. 62:2002;747-755.
41. George S.R., et al. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discov. 1:2002;808-820.
42. Angers S., et al. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42:2002;409-435.
43. Mellado M., et al. Receptor dimerization: a key step in chemokine signaling. Cell. Mol. Biol. 47:2001;575-582.
44. Eidne K.A., et al. Applications of novel resonance energy transfer techniques to study dynamic hormone receptor interactions in living cells. Trends Endocrinol. and Metabol. 13:2002;415-421.
45. Kroeger K.M., et al. Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer. J. Biol. Chem. 276:2001;12736-12743.
46. Cheng Z.J., Miller L.J. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J. Biol. Chem. 276:2001;48040-48047.
47. Latif R., et al. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor. J. Biol. Chem. 277:2001;45059-45067.
48. McVey M., et al. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human δ-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J. Biol. Chem. 276:2001;14092-14099.
49. Ayoub M.A., et al. Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J. Biol. Chem. 277:2002;21522-21528.
50. Babcock G.J., et al. Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J. Biol. Chem. 278:2003;3378-3385.
51. Janetopoulos C., et al. Receptor-mediated activation of heterotrimeric G-proteins in living cells. Science. 291:2001;2408-2411.
52. Janetopoulos C., Devreotes P. Monitoring receptor-mediated activation of heterotrimeric G-proteins by fluorescence resonance energy transfer. Methods. 27:2002;366-373.
53. Hughes T.E., et al. Visualization of a functional Gα q-green fluorescent protein fusion in living cells. Association with the plasma membrane is disrupted by mutational activation and by elimination of palmitoylation sites, but not by activation mediated by receptors or AlF4. J. Biol. Chem. 276:2001;4227-4235.
54. Leaney J.L., et al. A novel strategy to engineer functional fluorescent inhibitory G-protein α subunits. J. Biol. Chem. 277:2002;28803-28809.
55. Yu J.Z., Rasenick M.M. Real-time visualization of a fluorescent G(α)(s): dissociation of the activated G protein from plasma membrane. Mol. Pharmacol. 61:2002;352-359.
56. Adie E.J., et al. A pH-sensitive fluor, CypHer 5, used to monitor agonist-induced G protein-coupled receptor internalization in live cells. BioTechniques. 33:2002;1152-1157.
57. Adie, E.J. et al. CypHer 5 - a generic approach for measuring the activation and trafficking of G-protein-coupled receptors in live cells. Assays Drug Develop. Tech. (in press).
58. Kim J., et al. Regulation of epidermal growth factor receptor internalization by G protein-coupled receptors. Biochemistry. 42:2003;2887-2894.
59. Maudsley S., et al. The β(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J. Biol. Chem. 275:2000;9572-9580.
60. Daub H., et al. Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 16:1997;7032-7044.